$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
FDA批准Idecabtagene Vicleucel用于复发/难治性多发性骨髓瘤
2025-10-19 11:44:20
Check Details
多发性骨髓瘤最高缓解率达73%!三联疗法显神威
2025-10-19 11:44:20
Check Details
雷利度胺2020年国内最新价格
2025-10-19 11:44:20
Check Details
雷利度胺国内上市了没呢?
2025-10-19 11:44:20
Check Details
雷利度胺治疗多发性骨髓瘤疗效怎样呢?
2025-10-19 11:44:20
Check Details
雷利度胺对多发性骨髓瘤患者有多大的效果呢?
2025-10-19 11:44:20
Check Details
雷利度胺适用于什么病症呢?
2025-10-19 11:44:20
Check Details
雷利度胺治疗多发性骨髓瘤效果好吗?
2025-10-19 11:44:20
Check Details
雷利度胺适合什么人用?
2025-10-19 11:44:20
Check Details
用雷利度胺治疗期间要注意什么?
2025-10-19 11:44:20
Check Details
雷利度胺2020年纳入医保了吗?
2025-10-19 11:44:20
Check Details
来那度胺目前已知获批适应症有哪些?
2025-10-19 11:44:20
Check Details
1
2
...
1033
1034
1035
1036
1037
1038
1039
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
2
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
3
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
4
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
5
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
6
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
7
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
8
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
9
Pemigatinib for FGFR2-Rearranged Cholangiocarcinoma: Eligibility, Response Limits, Hyperphosphatemia and Ocular Monitoring
10
Cabozantinib with Aspirin: Additive Bleeding Risk, Do Not Stop Cardiac Aspirin Alone, Urgent Warning Signs
11
Zongertinib for HER2-Mutant NSCLC: First-Line ORR About 76%, Brain Metastases Controlled, Manage Diarrhea and Hepatotoxicity
12
Selpercatinib Traditional Approval for RET Fusion Solid Tumors: Weight-Based Adults, BSA-Based Pediatrics, Monitor Liver, BP, QT